Positron emission tomography as a surrogate marker for evaluation of treatment response in patients with desmoid tumors under therapy with imatinib

We used 2-deoxy-2-[18F] fluoro-D-glucose (FDG) positron emission tomography (PET) to evaluate patients with desmoid tumors undergoing therapy with imatinib. The study included 22 patients with progressive disease (PD) of a biopsy proven desmoid tumor treated orally with imatinib 800 mg daily. Patien...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Kasper, Bernd (VerfasserIn) , Dimitrakopoulou-Strauss, Antonia (VerfasserIn) , Pilz, Lothar R. (VerfasserIn) , Strauss, Ludwig G. (VerfasserIn) , Sachpekidis, Christos (VerfasserIn) , Hohenberger, Peter (VerfasserIn)
Dokumenttyp:	Article (Journal)
Sprache:	Englisch
Veröffentlicht:	16 May 2013
In:	BioMed research international Year: 2013, Jahrgang: 2013, Pages: 1-7
ISSN:	2314-6141
DOI:	10.1155/2013/389672
Online-Zugang:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1155/2013/389672 Verlag, lizenzpflichtig, Volltext: https://www.hindawi.com/journals/bmri/2013/389672/
Verfasserangaben:	Bernd Kasper, Antonia Dimitrakopoulou-Strauss, Lothar R. Pilz, Ludwig G. Strauss, Christos Sachpekidis, and Peter Hohenberger

Positron emission tomography as a surrogate marker for evaluation of treatment response in patients with desmoid tumors under therapy with imatinib von Kasper, Bernd (VerfasserIn) , Dimitrakopoulou-Strauss, Antonia (VerfasserIn) , Pilz, Lothar R. (VerfasserIn) , Strauss, Ludwig G. (VerfasserIn) , Sachpekidis, Christos (VerfasserIn) , Hohenberger, Peter (VerfasserIn) ,

in: BioMed research international, 2013 (2013), Seite 1-7

Article (Journal)

Positron emission tomography as a surrogate marker for evaluation of treatment response in patients with desmoid tumors under therapy with imatinib

Ähnliche Einträge